{"entity":{"type":"insider","cik":"0001722360","url":"/insider/0001722360","json_url":"/insider/0001722360.json","name":"Stark David Matthew","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":20,"first":"2018-03-14","last":"2025-11-12","span_basis":"filed_date"},"name_variants":[{"name":"Stark David Matthew","source":"filing","n_filings":20,"first_seen":"2018-03-14","last_seen":"2025-11-12"}],"transactions":[{"id":4987123,"accession":"0001104659-25-110557","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-110557","line_url":"/filing/0001104659-25-110557#line-1","is_derivative":false,"issuer_cik":"0001722360","issuer_name":"Assertio Holdings, Inc.","issuer_ticker":"ASRT","issuer_name_source":null,"issuer_url":"/issuer/0001722360","owner_cik":"0001722360","owner_name":"Stark David Matthew","owner_display_name":"Stark David Matthew","owner_url":"/insider/0001722360","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8959.0,"shares_display":"8,959","price_per_share":0.7597,"price_display":"0.76","price_state":"stated","total_value":6806.1523,"total_display":"6,806.15","total_whole":"6,806","shares_owned_after":98541.0,"shares_owned_after_display":"98,541","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-10","filed_date":"2025-11-12","scope":"insider"},{"id":8289001,"accession":"0001209191-23-017161","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-017161","line_url":"/filing/0001209191-23-017161#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001722360","owner_name":"Stark David Matthew","owner_display_name":"Stark David Matthew","owner_url":"/insider/0001722360","role":"Officer (Exec. VP Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Exec. VP Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49475.0,"shares_display":"49,475","price_per_share":9.4279,"price_display":"9.43","price_state":"stated","total_value":466445.3525,"total_display":"466,445.35","total_whole":"466,445","shares_owned_after":2974.39,"shares_owned_after_display":"2,974.39","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-07","filed_date":"2023-03-08","scope":"insider"},{"id":8288996,"accession":"0001209191-23-017161","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-017161","line_url":"/filing/0001209191-23-017161#line-1","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001722360","owner_name":"Stark David Matthew","owner_display_name":"Stark David Matthew","owner_url":"/insider/0001722360","role":"Officer (Exec. VP Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Exec. VP Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16491.0,"shares_display":"16,491","price_per_share":9.9309,"price_display":"9.93","price_state":"stated","total_value":163770.4719,"total_display":"163,770.47","total_whole":"163,770","shares_owned_after":52449.39,"shares_owned_after_display":"52,449.39","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-06","filed_date":"2023-03-08","scope":"insider"},{"id":8627909,"accession":"0001209191-23-014442","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-014442","line_url":"/filing/0001209191-23-014442","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001722360","owner_name":"Stark David Matthew","owner_display_name":"Stark David Matthew","owner_url":"/insider/0001722360","role":"Officer (Exec. VP Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Exec. VP Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63383.0,"shares_display":"63,383","price_per_share":9.8866,"price_display":"9.89","price_state":"stated","total_value":626642.3678,"total_display":"626,642.37","total_whole":"626,642","shares_owned_after":2974.39,"shares_owned_after_display":"2,974.39","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-28","filed_date":"2023-03-02","scope":"insider","n_lines":2},{"id":6497164,"accession":"0001209191-22-043422","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-043422","line_url":"/filing/0001209191-22-043422#line-1","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001722360","owner_name":"Stark David Matthew","owner_display_name":"Stark David Matthew","owner_url":"/insider/0001722360","role":"Officer (Exec. VP Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Exec. VP Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":58163.0,"shares_display":"58,163","price_per_share":9.0365,"price_display":"9.04","price_state":"stated","total_value":525589.9495,"total_display":"525,589.95","total_whole":"525,590","shares_owned_after":2974.39,"shares_owned_after_display":"2,974.39","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-28","filed_date":"2022-07-29","scope":"insider"},{"id":6389213,"accession":"0001209191-22-017063","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-22-017063","line_url":"/filing/0001209191-22-017063#line-6","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001722360","owner_name":"Stark David Matthew","owner_display_name":"Stark David Matthew","owner_url":"/insider/0001722360","role":"Officer (Exec. VP Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Exec. VP Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9057.0,"shares_display":"9,057","price_per_share":7.3667,"price_display":"7.37","price_state":"stated","total_value":66720.2019,"total_display":"66,720.20","total_whole":"66,720","shares_owned_after":61137.39,"shares_owned_after_display":"61,137.39","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-07","filed_date":"2022-03-08","scope":"insider"},{"id":6389208,"accession":"0001209191-22-017063","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-017063","line_url":"/filing/0001209191-22-017063","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001722360","owner_name":"Stark David Matthew","owner_display_name":"Stark David Matthew","owner_url":"/insider/0001722360","role":"Officer (Exec. VP Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Exec. VP Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23254.0,"shares_display":"23,254","price_per_share":7.4825,"price_display":"7.48","price_state":"stated","total_value":173998.055,"total_display":"173,998.06","total_whole":"173,998","shares_owned_after":42311.39,"shares_owned_after_display":"42,311.39","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-04","filed_date":"2022-03-08","scope":"insider","n_lines":2},{"id":6204234,"accession":"0001209191-22-014475","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-014475","line_url":"/filing/0001209191-22-014475#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001722360","owner_name":"Stark David Matthew","owner_display_name":"Stark David Matthew","owner_url":"/insider/0001722360","role":"Officer (Exec. VP Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Exec. VP Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6452.0,"shares_display":"6,452","price_per_share":8.1422,"price_display":"8.14","price_state":"stated","total_value":52533.4744,"total_display":"52,533.47","total_whole":"52,533","shares_owned_after":21380.39,"shares_owned_after_display":"21,380.39","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-28","filed_date":"2022-03-02","scope":"insider"},{"id":6889405,"accession":"0001209191-22-008418","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-008418","line_url":"/filing/0001209191-22-008418#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001722360","owner_name":"Stark David Matthew","owner_display_name":"Stark David Matthew","owner_url":"/insider/0001722360","role":"Officer (Exec. VP Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Exec. VP Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6110.0,"shares_display":"6,110","price_per_share":9.0602,"price_display":"9.06","price_state":"stated","total_value":55357.822,"total_display":"55,357.82","total_whole":"55,358","shares_owned_after":9402.39,"shares_owned_after_display":"9,402.39","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-09","filed_date":"2022-02-10","scope":"insider"},{"id":4139364,"accession":"0001209191-21-032254","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-032254","line_url":"/filing/0001209191-21-032254#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001722360","owner_name":"Stark David Matthew","owner_display_name":"Stark David Matthew","owner_url":"/insider/0001722360","role":"Officer (Exec. VP Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Exec. VP Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37884.0,"shares_display":"37,884","price_per_share":10.2187,"price_display":"10.22","price_state":"stated","total_value":387125.2308,"total_display":"387,125.23","total_whole":"387,125","shares_owned_after":2974.39,"shares_owned_after_display":"2,974.39","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-11","filed_date":"2021-05-13","scope":"insider"},{"id":5467182,"accession":"0001209191-21-018534","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-018534","line_url":"/filing/0001209191-21-018534#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001722360","owner_name":"Stark David Matthew","owner_display_name":"Stark David Matthew","owner_url":"/insider/0001722360","role":"Officer (Exec. VP Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Exec. VP Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13930.0,"shares_display":"13,930","price_per_share":10.5661,"price_display":"10.57","price_state":"stated","total_value":147185.773,"total_display":"147,185.77","total_whole":"147,186","shares_owned_after":2974.39,"shares_owned_after_display":"2,974.39","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-04","filed_date":"2021-03-08","scope":"insider"},{"id":4138280,"accession":"0001209191-21-015861","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-015861","line_url":"/filing/0001209191-21-015861#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001722360","owner_name":"Stark David Matthew","owner_display_name":"Stark David Matthew","owner_url":"/insider/0001722360","role":"Officer (Exec. VP Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Exec. VP Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18430.0,"shares_display":"18,430","price_per_share":10.8308,"price_display":"10.83","price_state":"stated","total_value":199611.644,"total_display":"199,611.64","total_whole":"199,612","shares_owned_after":2974.39,"shares_owned_after_display":"2,974.39","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-02","scope":"insider"},{"id":4362565,"accession":"0001209191-21-011247","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-011247","line_url":"/filing/0001209191-21-011247#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001722360","owner_name":"Stark David Matthew","owner_display_name":"Stark David Matthew","owner_url":"/insider/0001722360","role":"Officer (Exec. VP Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Exec. VP Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3926.0,"shares_display":"3,926","price_per_share":11.1229,"price_display":"11.12","price_state":"stated","total_value":43668.5054,"total_display":"43,668.51","total_whole":"43,669","shares_owned_after":2974.39,"shares_owned_after_display":"2,974.39","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-17","scope":"insider"},{"id":4821797,"accession":"0001209191-21-009646","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-009646","line_url":"/filing/0001209191-21-009646","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001722360","owner_name":"Stark David Matthew","owner_display_name":"Stark David Matthew","owner_url":"/insider/0001722360","role":"Officer (Exec. VP Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Exec. VP Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65312.0,"shares_display":"65,312","price_per_share":12.6945,"price_display":"12.69","price_state":"stated","total_value":829103.184,"total_display":"829,103.18","total_whole":"829,103","shares_owned_after":2974.39,"shares_owned_after_display":"2,974.39","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-11","scope":"insider","n_lines":2},{"id":2681240,"accession":"0001209191-20-020166","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-020166","line_url":"/filing/0001209191-20-020166#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001722360","owner_name":"Stark David Matthew","owner_display_name":"Stark David Matthew","owner_url":"/insider/0001722360","role":"Officer (Exec. VP Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Exec. VP Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2359.0,"shares_display":"2,359","price_per_share":7.1635,"price_display":"7.16","price_state":"stated","total_value":16898.6965,"total_display":"16,898.70","total_whole":"16,899","shares_owned_after":2974.39,"shares_owned_after_display":"2,974.39","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-17","filed_date":"2020-03-19","scope":"insider"},{"id":2433688,"accession":"0001209191-20-009881","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-009881","line_url":"/filing/0001209191-20-009881","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001722360","owner_name":"Stark David Matthew","owner_display_name":"Stark David Matthew","owner_url":"/insider/0001722360","role":"Officer (Exec. VP Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Exec. VP Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17016.0,"shares_display":"17,016","price_per_share":12.1422,"price_display":"12.14","price_state":"stated","total_value":206611.6752,"total_display":"206,611.68","total_whole":"206,612","shares_owned_after":6900.39,"shares_owned_after_display":"6,900.39","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-14","filed_date":"2020-02-18","scope":"insider","n_lines":2},{"id":2433361,"accession":"0001209191-20-008169","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-008169","line_url":"/filing/0001209191-20-008169#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001722360","owner_name":"Stark David Matthew","owner_display_name":"Stark David Matthew","owner_url":"/insider/0001722360","role":"Officer (Exec. VP Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Exec. VP Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12538.0,"shares_display":"12,538","price_per_share":12.2405,"price_display":"12.24","price_state":"stated","total_value":153471.389,"total_display":"153,471.39","total_whole":"153,471","shares_owned_after":2974.39,"shares_owned_after_display":"2,974.39","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-10","filed_date":"2020-02-11","scope":"insider"},{"id":8118388,"accession":"0001209191-19-020160","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-020160","line_url":"/filing/0001209191-19-020160#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001722360","owner_name":"Stark David Matthew","owner_display_name":"Stark David Matthew","owner_url":"/insider/0001722360","role":"Officer (Exec. VP Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Exec. VP Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2358.0,"shares_display":"2,358","price_per_share":16.43,"price_display":"16.43","price_state":"stated","total_value":38741.94,"total_display":"38,741.94","total_whole":"38,742","shares_owned_after":2974.39,"shares_owned_after_display":"2,974.39","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-18","filed_date":"2019-03-19","scope":"insider"},{"id":8390243,"accession":"0001209191-19-019334","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-019334","line_url":"/filing/0001209191-19-019334#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001722360","owner_name":"Stark David Matthew","owner_display_name":"Stark David Matthew","owner_url":"/insider/0001722360","role":"Officer (Exec. VP Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Exec. VP Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2444.0,"shares_display":"2,444","price_per_share":15.82,"price_display":"15.82","price_state":"stated","total_value":38664.08,"total_display":"38,664.08","total_whole":"38,664","shares_owned_after":2974.39,"shares_owned_after_display":"2,974.39","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-12","filed_date":"2019-03-14","scope":"insider"},{"id":7800340,"accession":"0001209191-19-010841","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-010841","line_url":"/filing/0001209191-19-010841#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001722360","owner_name":"Stark David Matthew","owner_display_name":"Stark David Matthew","owner_url":"/insider/0001722360","role":"Officer (Exec. VP Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Exec. VP Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3926.0,"shares_display":"3,926","price_per_share":17.74,"price_display":"17.74","price_state":"stated","total_value":69647.24,"total_display":"69,647.24","total_whole":"69,647","shares_owned_after":2974.39,"shares_owned_after_display":"2,974.39","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-14","filed_date":"2019-02-19","scope":"insider"},{"id":6494552,"accession":"0001209191-18-020867","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-020867","line_url":"/filing/0001209191-18-020867#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001722360","owner_name":"Stark David Matthew","owner_display_name":"Stark David Matthew","owner_url":"/insider/0001722360","role":"Officer (Exec. VP Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Exec. VP Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2358.0,"shares_display":"2,358","price_per_share":18.38,"price_display":"18.38","price_state":"stated","total_value":43340.04,"total_display":"43,340.04","total_whole":"43,340","shares_owned_after":2974.39,"shares_owned_after_display":"2,974.39","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-19","filed_date":"2018-03-20","scope":"insider"},{"id":6290361,"accession":"0001209191-18-019572","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-019572","line_url":"/filing/0001209191-18-019572#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001722360","owner_name":"Stark David Matthew","owner_display_name":"Stark David Matthew","owner_url":"/insider/0001722360","role":"Officer (Exec. VP Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Exec. VP Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2441.0,"shares_display":"2,441","price_per_share":19.2,"price_display":"19.20","price_state":"stated","total_value":46867.2,"total_display":"46,867.20","total_whole":"46,867","shares_owned_after":2974.39,"shares_owned_after_display":"2,974.39","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-12","filed_date":"2018-03-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":26,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":26,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":26},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001808665","name":"Assertio Holdings, Inc.","url":"/issuer/0001808665","role":"Director","n_filings":1,"first_seen":"2025-11-12","last_seen":"2025-11-12"},{"type":"issuer","type_label":"ISSUER","cik":"0000818686","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","url":"/issuer/0000818686","role":"Officer (Exec. VP Chief Legal Officer)","n_filings":19,"first_seen":"2018-03-14","last_seen":"2023-03-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001722360","retrieved_at":"2026-08-26T12:35:19+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}